Advertisement
Screener

Elite Pharmaceuticals, Inc. (ELTP) Share-based Compensation Arrangement by Share-based Payment Award, Non-Option Equity Instruments, Outstanding, Number

2.0 / 5 stars · 41/105 Roast Me

Elite Pharmaceuticals, Inc. Share-based Compensation Arrangement by Share-based Payment Award, Non-Option Equity Instruments, Outstanding, Number

Elite Pharmaceuticals, Inc. (ELTP) had Share-based Compensation Arrangement by Share-based Payment Award, Non-Option Equity Instruments, Outstanding, Number of 79.01 million shares as of 2022-06-30, per its 10-Q filed 2022-08-15.

Discontinued › Notes › Share-Based Payment Arrangement, Disclosure

us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsOutstandingNumber · last filed 2022-08-15

  • 2022-06-30: Share-based Compensation Arrangement by Share-based Payment Award, Non-Option Equity Instruments, Outstanding, Number 79.01M shares.
  • 2022-03-31: Share-based Compensation Arrangement by Share-based Payment Award, Non-Option Equity Instruments, Outstanding, Number 79.01M shares.
  • 2021-12-31: Share-based Compensation Arrangement by Share-based Payment Award, Non-Option Equity Instruments, Outstanding, Number 79.01M shares.
  • 2021-06-30: Share-based Compensation Arrangement by Share-based Payment Award, Non-Option Equity Instruments, Outstanding, Number 79.01M shares.
Period endShare-based Compensation Arrangement by Share-based Payment Award, Non-Option Equity Instruments, Outstanding, Number
2022-06-3079.01M shares
10-Q · filed 2022-08-15
2022-03-3179.01M shares
10-Q · filed 2022-08-15
2021-12-3179.01M shares
10-Q · filed 2022-02-14
2021-06-3079.01M shares
10-Q · filed 2022-08-15
2021-03-3179.01M shares
10-Q · filed 2022-08-15
2020-03-3179.01M shares
10-K · filed 2022-06-29